Industry Insights
Industry Leaders Provide an Update on COVID-19 Vaccine Progress
Industry InsightA number of biopharmaceutical industry leaders met in a virtual press conference today to outline progress in COVID-19 vaccine development. Here's what they had to say.
Read More
Real-time Antibody Titer Monitoring Advances Bioprocessing Capabilities
Industry InsightIn facilitating the move to continuous processing in biotherapeutic production, bioprocessing specialists are being driven to develop innovative analytical testing methods for key measurements of output and quality, such as antibody titer.
Read More
Three Definitely Isn't a Crowd When It Comes to Protein Complex Analysis
Industry InsightIn a study published in Cell Reports, members of the Washburn Lab described their three-pronged approach to analyzing protein complexes – affinity tag protein purification, chemical crosslinking with high-resolution mass spectrometry and computational molecular modeling with protein docking. We interviewed Washburn to find out more.
Read More
Developing the World's First Single Molecule Protein Sequencer
Industry InsightJagannath Swaminathan is the co-founder of Erisyon and a researcher at the Marcotte Lab at the University of Texas Austin. In this interview, we discuss the concept of next-generation protein sequencing, clinical proteomics and the critical role of protein sequencing in the fight against COVID-19.
Read More
Innovative Spectroscopy Is Enhancing Protein Structure Determination
Industry InsightProteins are central to many disciplines within the life sciences, not least protein-based pharmaceuticals. Changes in protein conformation, structure or interactions could have significant impact on efficacy and safety. Therefore, being able to understand what forms of a protein are present in their natural conditions, even if present only at low levels, is important for analysts.
Read More
Using Bioprinted Tissue Models To Test Drugs Against Diseases Including COVID-19
Industry InsightTechnology Networks recently had the pleasure of speaking with Keith Murphy, CEO and founder of Viscient Biosciences to learn about the company's expertise in 3D disease models and multi-omics drug discovery approaches, and how they are using these techniques to test drugs against SARS-CoV-2 using bioprinted lung tissue.
Read More
Leading the Movement Towards Direct Cell Conversion: An Interview With Mogrify
Industry InsightTechnology Networks recently spoke with Joe Foster, COO, Mogrify, to learn about the biotech company's proprietary platform, the challenges encountered in developing cell therapies and to gain Mogrify's insights on the future of this exciting research space.
Read More
High Sensitivity Proteomics: Immunopeptidomics
Industry InsightTechnology Networks recently spoke with Gary Kruppa, PhD, Vice President of Proteomics, Bruker Daltonics Inc., to learn more about the advancing research area immunopeptidomics, and to discuss the current status of single cell proteomics.
Read More
Proteomics Lends a Hand in the Fight Against COVID-19
Industry InsightTechnology Networks spoke with Stephen Williams, Chief Medical Officer of SomaLogic, to learn about how proteomics can contribute to the fight against COVID-19 and the availability of the SomaScan Assay at this critical time.
Read More
Collaboration To Develop Gene-encoded Antibody Vaccine Against COVID-19 Is Underway
Industry InsightSorrento Therapeutics Inc. and SmartPharm Therapeutics Inc. recently announced a research and development collaboration in which they will work to develop a next-generation, gene-encoded antibody vaccine for COVID-19. Technology Networks spoke with SmartPharm's CEO Jose Trevejo to learn more about the collaboration and the next steps in the development of the vaccine.
Read More
